Talk:Covaxin

Requested move 9 May 2021

 * The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion. 

The result of the move request was: page moved. Murtaza.aliakbar (talk) 09:23, 16 May 2021 (UTC)

BBV152 → Covaxin – As per WP:COMMONNAME. Bharat Biotech, the developing company markets it as COVAXIN. They are developing another vaccine, but that's not named commercially, so it's BBV154 only. Whereas, COVAXIN case is the opposite, bharatbiotech.com  Saha ❯❯❯  Stay safe    18:08, 9 May 2021 (UTC)
 * Edit to the move request, BBV152 → Covaxin.  Saha ❯❯❯  Stay safe    05:30, 10 May 2021 (UTC)
 * I have modified the request per above. Run n Fly (talk) 17:10, 10 May 2021 (UTC)

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.
 * Support and move to Covaxin as COVAXIN is not an abbreviation. Thus, capitalization is unnecessary per MOS:ABBR. Run n Fly (talk) 19:33, 9 May 2021 (UTC)
 * Support move to Covaxin per WP MOS In ictu oculi (talk) 20:35, 9 May 2021 (UTC)
 * Move to Covaxin per MOS:CAPS. The vaccines usually doesn't have a acronym or capitalization. 110.137.161.129 (talk) 20:53, 9 May 2021 (UTC)
 * Support Covaxin (not all caps) per the above. While the "technical names" were good early on, we now have common names for many of these vaccines and should consider moving all of them for which a common name has arisen - keeping in mind that in some cases it may be the trade name (as it is here), and in others it may not (as in Pfizer-BioNTech). -bɜ:ʳkənhɪmez (User/say hi!) 00:24, 10 May 2021 (UTC)
 * support per above editors--Ozzie10aaaa (talk) 11:46, 10 May 2021 (UTC)
 * Support Unlike other COVID-19 vaccines, which are usually known by their manufacturer's name (ex. Pfizer/Astra-Zeneca/J&J [COVID-19] vaccine) and have various other names which are not as well known (Covishield may be an exception, but that is India only), this one is usually called "Covaxin" in Indian media (and probably in the media of other countries too now). MSG17 (talk) 14:52, 10 May 2021 (UTC)
 * Support - trade name per MOS:COMMONNAMEDede2008 (talk) 08:23, 11 May 2021 (UTC)
 * support Common name and easy to understand Jaswinder1122 (talk) 11:12, 11 May 2021 (UTC)
 * Support renaming to Covaxin based on the widespread adoption by various sources. --Fernando Trebien (talk) 17:12, 13 May 2021 (UTC)
 * Support renaming to Covaxin: It is known under that name here in Paraguay where I live, and have received it this morning. No-one knows BBV152 here. (Paraguay being one of the few countries in South America that has authorised its use) Renaud OLGIATI (talk) 19:59, 13 May 2021 (UTC)
 * Support renaming to Covaxin: It is widely known under the name Covaxin here in India. No one actually knows what BBV152 is. Also the brand name COVAXIN® is registered by the company Bharat Biotech responsible for its development and manufacturing in India. (talk) 09:14, 14 May 2021 (UTC)
 * Support almost entirely known as Covaxin only. extra 999  ( talk ) 13:28, 14 May 2021 (UTC)

A Commons file used on this page or its Wikidata item has been nominated for deletion
The following Wikimedia Commons file used on this page or its Wikidata item has been nominated for deletion: Participate in the deletion discussion at the. —Community Tech bot (talk) 07:02, 30 June 2021 (UTC)
 * Covaxin vial.jpg

Semi-protected edit request on 16 July 2021
The efficacy section is unclear, as it does not clearly specify the overall efficacy of the vaccine.

Please add to the section:

The overall efficacy of Covaxin in 77.8%.

Sources: https://timesofindia.indiatimes.com/india/covaxins-overall-efficacy-77-8-65-2-effective-against-delta-variant-bharat-biotech/articleshow/84087789.cms https://www.gavi.org/vaccineswork/indias-covaxin-vaccine-shows-high-efficacy-against-covid-19-infections-phase-3 Dhruv Malik (talk) 08:07, 16 July 2021 (UTC)
 * User:Dhruv Malik, We need to present all the cases. See for example (https://en.wikipedia.org/wiki/Oxford–AstraZeneca_COVID-19_vaccine#Effectiveness). Thus, its correctly represented and requires no change. 2402:3A80:6E3:2F77:7193:D3BB:C7EC:25DE (talk) 18:33, 21 July 2021 (UTC)

This is a 2-dose vaccine. Dosing interval is... how many weeks?
It should be mentioned in quite beginning of this article that this is a 2-dose vaccine.

--ee1518 (talk) 16:38, 4 September 2021 (UTC)

Semi-protected edit request on 12 November 2021
Please replace the phase-III preprint reference with this peer reviewed article at the Covaxin and Covaxin sections. 2402:3A80:6CF:BBB9:CD3F:2714:94D5:8EC5 (talk) 10:36, 12 November 2021 (UTC)
 * ✅ Abrilando232 (talk) 04:54, 13 November 2021 (UTC)

9165090187
9165090187 — Preceding unsigned comment added by 2409:4043:4C81:3D22:7021:FEB3:28BD:F663 (talk) 13:35, 22 February 2022 (UTC)